Neurofilament in clinical practice: Is the multiple sclerosis community ready?

被引:4
|
作者
Moccia, Marcello [1 ,2 ,3 ]
Terracciano, Daniela [4 ]
Brescia Morra, Vincenzo
Castaldo, Giuseppe [2 ,5 ]
机构
[1] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Via Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy
[3] Policlin Federico II Univ Hosp, Multiple Sclerosis Unit, Naples, Italy
[4] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[5] Ctr Adv Biotechnol CEINGE, Naples, Italy
关键词
LIGHT;
D O I
10.1177/13524585241246536
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:643 / 645
页数:3
相关论文
共 50 条
  • [1] Exploring neurofilament light in csf as a biomarker for multiple sclerosis in clinical practice
    Rosenstein, I.
    Novakova, L.
    Axelsson, M.
    Blennow, K.
    Zetterberg, H.
    Lycke, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 156 - 157
  • [2] From neurofilament research to multiple sclerosis clinical practice Where do we stand?
    Bodini, Benedetta
    Calabresi, Peter Arthur
    NEUROLOGY, 2017, 88 (09) : 816 - 817
  • [3] Whole brain volume quantification in multiple sclerosis: ready for translation into clinical practice?
    Beadnall, Heidi
    Wang, Chenyu
    Burke, Therese
    Oliver, Ruth
    Hatton, Sean
    Barton, Joshua
    Ly, Linda
    Vucic, Steve
    Barnett, Michael
    NEUROLOGY, 2016, 86
  • [4] Whole brain volume quantification in multiple sclerosis: ready for translation into clinical practice?
    Beadnall, Heidi
    Wang, Chenyu
    Burke, Therese
    Oliver, Ruth
    Hatton, Sean
    Barton, Joshua
    Ly, Linda
    Vucic, Steve
    Barnett, Michael
    NEUROLOGY, 2016, 86
  • [5] Serum neurofilament light (NfL) for disease prognosis and treatment monitoring in multiple sclerosis patients: is it ready for implementation into clinical care?.
    Calabresi, P.
    Kuhle, J.
    Arnold, D. L.
    Singh, C. M.
    Kinkel, R. P.
    Kappos, L.
    Sangurdekar, D.
    de Moor, C.
    Engle, B.
    Su, R.
    Deykin, A.
    Fisher, E.
    Sandrock, A.
    Kieseier, B. C.
    Rudick, R. A.
    Plavina, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 59 - 60
  • [6] Developing multiple sclerosis practice guidelines: The Multiple Sclerosis Council for Clinical Practice Guidelines
    Miller, DM
    Shindell, S
    Lublin, F
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 519 - 519
  • [7] Mitoxantrone for multiple sclerosis in clinical practice
    Rizvi, SA
    Zwibel, H
    Fox, EJ
    NEUROLOGY, 2004, 63 (12) : S25 - S27
  • [8] Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
    van Lierop, Zoe Y. G. J.
    Wessels, Mark H. J.
    Lekranty, Womei M. L.
    Moraal, Bastiaan
    Hof, Sam N.
    Hogenboom, Laura
    de Jong, Brigit A.
    Meijs, Nandi
    Mensing, Liselore A.
    van Oosten, Bob W.
    Sol, Nik
    Kempen, Zoe L. E. van
    Vermunt, Lisa
    Willems, Myrthe J.
    Strijbis, Eva M. M.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Teunissen, Charlotte E.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (13) : 1620 - 1629
  • [9] Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis
    Nicolella, Valerio
    Fiorenza, Mariano
    Monteiro, Isabel
    Novarella, Federica
    Sirica, Rosa
    'Angelo, Martina
    Carbone, Gianluigi
    La Civita, Evelina
    Esposito, Antonio
    Criscuolo, Vincenzo
    Carotenuto, Antonio
    Petracca, Maria
    Lanzillo, Roberta
    Castaldo, Giuseppe
    Morra, Vincenzo Brescia
    Terracciano, Daniela
    Moccia, Marcello
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 463
  • [10] Natalizumab Treatment for Multiple Sclerosis in Clinical Practice
    Thyerlei, Dinah
    Hillman, Lynda
    Woolvett, Valerie
    Krasucki, Dora
    Wundes, Annette
    NEUROLOGY, 2010, 74 (09) : A554 - A554